neoantigen peptide-based vaccine (Pepscan Systems)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameneoantigen peptide-based vaccine (Pepscan Systems)
Drug Alias Namepersonalized neoantigen peptide vaccine (Pepscan Systems)
ClassificationBiologics > Antigen > Tumor antigenVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMetastatic breast cancerSolid tumoursUterine Cervical Neoplasms +[19] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPepscan Systems
China Registration ClassN/A

Develop Information

Active CompaniesPepscan Systems
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerSolid tumoursUterine Cervical Neoplasms +[19] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A